Don't believe the hype that insurance companies are getting squeezed on Obamacare. That's the message from Ezekiel Emanuel, one of the law's architects.» Read More
After a huge two week really, is Tuesday's market weakness an early sign of a sharp pull back or nothing more than expected profit taking?
So far this quarter, only one S&P healthcare company, Aetna, has missed its consensus EPS estimate. This week there are over 20 more healthcare companies reporting. Yesterday after the bell Amgen blew the cover off the ball with a 40% rise in earnings and this morning, Teva Pharmaceuticals beat by three cents per share.
From boardrooms to waiting rooms across the nation people are intently debating the future of healthcare. But no matter how it plays out, healthcare stocks may be winners!
In the final minutes of trading the bulls foiled the bears and sent both the S&P 500 and Dow higher as investors rotated into financials...
Stocks eked out a gain Monday as banks got a boost from a jump in new-home sales. Stocks had struggled for much of the day as investors worried about a a record $200 billion in Treasury auctions this week and lowered outlooks from Honeywell and Aetna cast a shadow over the market.
The Dow poked into positive territory Monday afternoon, led by Bank of America, as a jump in new-home sales buoyed bank stocks. Still, the blue-chip index struggled to stay above water as worries about a record $200 billion in Treasury auctions this week and lowered outlooks from Honeywell and Aetna cast a shadow over the market.
With nearly 150 more companies due to flood the Street with earnings the bulls appear to be getting a little tired. Is this the pause that refreshes or are investors growing concerned?
Stocks got a quick pop Monday after a sharp jump in new home sales, but quickly resumed their decline as lowered outlooks from Honeywell and Aetna cast a shadow over the market.
While the public is continuing to obsess over the generally better than expected earnings and the two-week, 100 point rise in the S&P 500 (11 percent), stock traders are nervously eyeing the $200 billion in new Treasury debt that is coming this week.
Stock index futures edged higher ahead of the open Monday as investors look to see if the summer rally will keep pushing the major indexes higher.
A general air of uncertainty over what Washington has in store for health care reform is spreading to Wall Street, where investors are leery over what ramifications the undertaking will have on portfolios.
With UnitedHealthcare due to report earnings on Tuesday, Wall Street is taking close notice of late developments in the area of healthcare reform.
Now is not the time to get overly pessimistic about the U.S. economy, said Mary Jane Matts, director of large cap value strategies at Fifth Third Asset Management.
Following are the day’s biggest winners and losers. Find out why shares of Family Dollar and Peabody Energy popped while Advanced Micro Devices and Aetna dropped.
Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!
The S&P 500 fell to its lowest level in 10 weeks on Tuesday as talk of a second government stimulus plan heightened fears that the economy remains weak.
Health insurance is supposed to offer protection — both medically and financially. But as it turns out, an estimated three-quarters of people who are pushed into personal bankruptcy by medical problems actually had insurance when they got sick or were injured.
Following are the week’s biggest winners and losers. Find out why shares of Aetna and Perfect World popped while Caterpillar and Wells Fargo dropped.
Stocks fell to the lows of the day this afternoon as a couple of issues weighed on the markets.
One stock in particular should benefit now that Washington’s plans are coming into focus.